Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Molly Ann Maloney, M.S.

Concepts (13)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Molly Maloney's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Molly Maloney has written about over time.
Cross-Sectional Studies, 1 publications between 2021 and 2021, average publication date August 2021. Substance-Related Disorders, 1 publications between 2021 and 2021, average publication date August 2021. Humans, 3 publications between 2021 and 2023, average publication date September 2022. Gender Identity, 1 publications between 2022 and 2022, average publication date December 2022. Risk Factors, 1 publications between 2022 and 2022, average publication date December 2022. Adult, 1 publications between 2023 and 2023, average publication date July 2023. Aggression, 1 publications between 2023 and 2023, average publication date July 2023. Alcoholic Intoxication, 1 publications between 2023 and 2023, average publication date July 2023. Emotions, 1 publications between 2023 and 2023, average publication date July 2023. Female, 1 publications between 2023 and 2023, average publication date July 2023. Male, 1 publications between 2023 and 2023, average publication date July 2023. Sexual Partners, 1 publications between 2023 and 2023, average publication date July 2023. Young Adult, 1 publications between 2023 and 2023, average publication date July 2023.

To see the data from this visualization as text, click here.
Maloney's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.